21 results about "Memory Losses" patented technology

The invention discloses a pre-inquiry method based on a long and short term memory management large model. The pre-inquiry method comprises the following steps: S100, acquiring identity information and complaint symptom information of a patient; s200, establishing long-term memory and short-term memory corresponding to the patient; all information generated in the pre-inquiry dialogue process is stored in the short-term memory; the long-term memory and the short-term memory are updated and maintained based on a memory storage mechanism; s300, based on the long-term memory and the short-term memory, using a large model to construct multiple rounds of pre-inquiry dialogues, and obtaining patient condition information; and S400, summarizing the patient identity information, the complaint symptom information, the long-term memory and the short-term memory to generate a pre-inquiry report. According to the pre-inquiry method based on the long-short-term memory management large model, the long-short-term memory management is separated from the large model to carry out multiple rounds of pre-inquiry dialogues, the method does not need to depend on the memory ability of the large model, and the memory loss phenomenon in multiple rounds of dialogues commonly seen in an existing large model can be effectively avoided.

The invention provides a system and method for enhancing long-term memory of a large language model, and relates to the technical field of artificial intelligence. The system solves the problems of memory loss, information confusion and the like in multiple rounds of dialogues through hierarchical memory storage, time-aware retrieval and an automatic reflection compression mechanism, improves response consistency and credibility, and supports personalized services and complex task scenes.

The application discloses a kind of multi-step flow prediction methods based on space-time dual attention long short-term memory network, belong to deep learning and water conservancy informatization technical field.The method includes: feature perception and data preprocessing, variable attention feature screening, LSTM time series dynamics coding, extract time series deep dependence and construct full-time domain dynamics memory bank;Dynamic retrieval and multi-dimensional feature fusion, introduce step condition embedding and time decay driven cross attention mechanism to realize on-demand retrieval of historical features, and fuse near-time physical evolution inertia to ensure trajectory continuity;Result mapping and trajectory output, generate multi-step flow prediction value in parallel.The application solves the problems of spatial driving weight static, phase lag, memory loss and trajectory discontinuity in tidal river network multi-step flow prediction, and improves the prediction accuracy and stability.

Smell loss (hyposmia) is a common cognitive deficit perceived clinically as a nasal abnormality but, in reality, it is a deficit of complex biochemical detection and processing of externally generated chemical events. A major mechanism initiating hyposmia involves abnormalities of growth of human olfactory cells through altered growth factor stimulation of stem cell activity. While several growth factors are involved well known signaling substances generate and perpetuate this process; among these substances are cAMP and cGMP. We have hypothesized a role for cAMP in taste and olfaction as a growth factor necessary for stem cell maturation. We have thus measured cAMP and cGMP in parotid saliva of 19 normal subjects and 144 patients with hyposmia to evaluate roles for these signals in cognition. Results indicate that patients secrete significantly less cAMP (0.40+ / −0.03 pmol / mg protein (Mean+ / −SEM); patients; 0.67+ / −0.09, normals, p<0.005) and significantly less cGMP (0.072+ / −0.003, patients; 0.100+ / −0.007, normals, p<0.005) than do normals. While parotid gland secretions relate directly to taste bud growth factors many substances secreted in saliva are similar to those secreted in nasal mucus. The present results indicate aberrant signaling in saliva may serve both as a marker for hyposmia and as an indicator of a mechanism which interferes with olfactory system function.

The invention discloses a brain-computer interface method and device for enhancing brain memory and function. The brain-computer interface device comprises a signal generating and sending device which comprises a micro sensor array chip capable of collecting signals of multiple frequencies. The signal generator of the device can send out trigger signals with different frequencies, including electrical signals, and the signal receiver can collect multi-frequency feedback signals of the brain for the trigger signals. The device may also assist the brain in holding information, optimizing writing and storage and reading of information, and optimizing addresses and distribution of information storage, including refreshing information and reformatting physical distribution of information storage, to improve efficiency and accuracy of writing, holding and reading of information. When the brain refreshes the memory, the device records and downloads the content of the information so as to backup the memory and prevent the memory loss problem. According to the invention, the information stored in the brain can be transferred to another region of the brain or the in-vitro information memory, and the brain information can be edited.

The present disclosure provides, among other things, human codon-optimized sequences encoding presenilin 1, and methods for using the sequences in gene therapy to treat neurodegenerative diseases including, but not limited to Alzheimer's disease, frontotemporal dementia, frontotemporal lobar degeneration, Pick's disease, Lewy body dementia, memory loss, and cognitive impairment including mild cognitive impairment (MCI).

The invention provides a composition containing melatonin and probiotics and application of the composition in the aspect of improving sleep. The composition can effectively improve sleep, reduce sleep latency, increase non-rapid eye movement sleep (NREM) time, improve immunity, protect gastrointestinal functions, improve intestinal health, relieve pressure and improve mood problems, inattention, cognitive dysfunction, memory deterioration and the like caused by sleep disorders.

The present disclosure provides, among other things, methods for using presenilin based gene therapy to treat neurodegenerative dementia including, but not limited to Alzheimers disease, frontotemporal dementia, frontotemporal lobar degeneration, Picks disease, Lewy body dementia, memory loss, and cognitive impairment including mild cognitive impairment (MCI).

The present invention discloses a structure for magnetic coils that integrate a magnetic stimulation device, wherein the arrangement of a plurality of magnetic coils generates a vortex magnetic field to stimulate areas of interest, for example, towards the hippocampus in the brain of a subject in order to reduce Tau protein phosphorylation, which is an indicator of cognitive process pathologies such as memory loss, learning difficulties or diseases such as Alzheimer's disease. The present invention integrates a magnetic emitter based on modular magnetic coils to generate a vortex magnetic field, either around a body part of a subject or on their head, chest or abdomen. Alternatively, the magnetic stimulation device has cooling means that reduce the temperature of the magnetic coils during their operation, in a slim, portable structural configuration. Control means are used to adjust the characteristics of the desired magnetic field and the area where it is applied by controlling the power and frequency provided to each of them.

Provided are oligomeric agents, pharmaceutical compositions, and methods for reducing the amount or activity of APOE RNA in a cell or subject, and in certain instances reducing the amount of ApoE protein in a cell or subject. Such oligomeric agents, pharmaceutical compositions, and methods are useful to ameliorate at least one symptom of a neurodegenerative disease. Such symptoms include cognitive impairment, progressive memory loss, a decline in language skills, behavioral abnormality, dementia, difficulty performing daily activities, aphasia, agnosia, apraxia, loss of motor function, amyloid plaque, neurofibrillary tangle, and / or neuroinflammation.

The application discloses a kind of composition and its application, the composition is suitable for such as student group etc. The crowd engaged in high-intensity brain work, can improve the cognitive function decline and nerve injury caused by "chronic sleep deprivation (CSD)". It contains traditional Chinese medicine decoction pieces (according to daily amount) are: prepared 4.5~13.5g rhizoma polygonati, mulberry 4.5~13.5g, medlar seed 4.5~13.5g, longan meat 3~9g, chrysanthemum 3~9g, dried tangerine or orange peel 1.5~4.5g. Its preparation method is: the above-mentioned natural medicine is extracted by water extraction method after being separated or mixed, and the extract is spray dried to prepare powder. The powder is mixed uniformly to prepare the concentrated product. The water extract components have synergistic effect, can significantly alleviate the insufficient sleep caused by long-term passive overtime, and then the cognitive function decline, memory loss and emotional regulation imbalance caused by neuron damage.

The present invention relates to a memory optimization method. The method matches the similarity between a page and other pages according to JS files and CSS files loaded by the pages. When similar pages are matched, a memory sharing layer 1 is established. A memory creation method is used to count the memory byte blocks 1 created, and a threshold for creating the memory byte 1 is set. The created memory byte blocks 1 are stored in the sharing layer 1. An address mapping relationship between the shared memory and the virtual memory address 1 of the browser page is established. Then, a memory reading method is used to read the memory sharing layer 1 memory when a mapping exists, otherwise the data is directly read. A memory modification method is used to modify unmapped memory and enter the memory sharing layer 1. If a mapping exists, the incremental modification content is recorded. The present invention can improve the memory usage of similar web pages, allow similar memory blocks to reuse the same memory, thereby reducing memory occupation and solving memory loss.

We provide a drug that uses herbal ingredients to help prevent and treat memory loss. [Solution] The formula contains at least red ginseng and Polygala tenuifolia, and in addition, Angelica sinensis, Ligusticum chuanxiong, Peony root, Rehmannia glutinosa, Glycyrrhiza uralensis, Poria cocos, Atractylodes macrocephala, Viper rhizome, Dioscorea japonica, Schisandra chinensis, and ox bile as active ingredients.

The present disclosure relates to the use of inositol-stabilized arginine (“ASI”) for improving cognition. For example, in some implementations, methods include administering an amount of ASI effective to improve cognition in humans. Some embodiments include the use of ASI for improving mental focus and / or attention span. For example, in some implementations, methods include administering an amount of ASI effective to improve mental focus and / or attention span in humans. Some embodiments include the use of ASI for treating and / or preventing cognitive disorders. Cognitive disorders may include stroke, anoxic brain injury, traumatic brain injury, dementia, Alzheimer's disease, Parkinson's disease, MCI, and age-related memory loss, attention deficit hyperactivity disorder (“ADHD”), and other learning disabilities.

Provided are oligomeric agents, pharmaceutical compositions, and methods for reducing the amount or activity of APOE RNA in a cell or subject, and in certain instances reducing the amount of ApoE protein in a cell or subject. Such oligomeric agents, pharmaceutical compositions, and methods are useful to ameliorate at least one symptom of a neurodegenerative disease. Such symptoms include cognitive impairment, progressive memory loss, a decline in language skills, behavioral abnormality, dementia, difficulty performing daily activities, aphasia, agnosia, apraxia, loss of motor function, amyloid plaque, neurofibrillary tangle, and / or neuroinflammation.

The invention discloses a construction method and application of a model for senescence with cognitive impairment and hypomnesia, and belongs to the technical field of medicine, health food and food efficacy evaluation. According to the senescence accompanied cognitive disorder and hypomnesia model construction method, zebra fish D-galactose is combined with physical stimulation induction to successfully establish the senescence accompanied cognitive disorder and hypomnesia model, phenomenon observation is visual, senescence accompanied cognitive disorder and hypomnesia definition is accurate, and the method is suitable for popularization and application. The method can effectively and rapidly evaluate the effects of medicines, health-care foods and foods in improving senescence accompanied by cognitive impairment and hypomnesia, and provides an effective and rapid detection approach for medicines, health-care foods and foods in improving senescence accompanied by cognitive impairment and hypomnesia.

The disclosure relates to double stranded ribonucleic acid (dsRNAi) agents and compositions targeting a Actin binding LIM protein 3 (ABLIM3) gene, as well as methods of inhibiting expression of an ABLIM3 gene and methods of treating subjects having an ABLIM3-associated disease or disorder, e.g., PTSD or age-related memory loss, using such dsRNAi agents and compositions.

The system according to the embodiment aims to enable patients with memory loss or dementia to search for information based on fragmented memories and analyze their responses. [Solution] A system according to an embodiment includes an input unit, a search unit, a display unit, a recording unit, and an analysis unit. The input unit inputs keywords. The search unit searches for information based on the keywords input by the input unit. The display unit displays the information searched for by the search unit. The recording unit records the user's reaction to the information displayed by the display unit. The analysis unit analyzes the reaction recorded by the recording unit.

The disclosure relates to nucleic acid expression cassettes for the treatment of neurodegenerative disorders. Methods of treating neurodegenerative disorders such as Alzheimer's disease, frontotemporal dementia, frontotemporal lobar degeneration, Pick's disease, Lewy body dementia, memory loss, cognitive impairment, and mild cognitive impairment are also provided.

The present invention discloses a sequence recommendation method based on attenuated emotion perception, and establishes a attenuated emotion memory network to simulate the dynamic nonlinear attenuation of human attenuated emotions. The memory network adopts an exponential memory loss function to calculate the attenuation rate of emotion according to the time interval between two adjacent items in the sequence, and uses the attenuation rate to adjust the long-term memory unit of the network at each moment to learn the true attenuated emotion characteristics. The present invention proposes a sequence recommendation model based on attenuated emotion perception, which processes two channels, namely emotion attenuation preference and user item preference, and fuses the two channels to obtain fused preferences to explore the user's potential preferences. The present invention can be applied to Chinese application scenarios to simulate the attenuation law of user emotions in the real world, construct a sequence recommendation model based on attenuated emotion perception, and extend its application to real scenarios and platforms containing Chinese text reviews.

The present invention relates to a composition for alleviating, preventing, or treating Alzheimer's disease, the composition comprising apigenin and oxyresveratrol. A composition according to the present invention is highly effective in reducing Alzheimer's disease pathology caused by β-amyloid, which is increased by aging and oxidative stress, and improving β-amyloid-induced memory loss and cognitive function.